Literature DB >> 34508273

Hippocampal sclerosis and epilepsy surgery in neurofibromatosis type 1: case report of a 3-year-old child explored by SEEG and review of the literature.

Claudine Sculier1, Delphine Taussig2,3, Alec Aeby4, Jerry Blustajn5, Olivier Bekaert3, Martine Fohlen6.   

Abstract

PURPOSE: Epilepsy associated with neurofibromatosis type 1 (NF1) is infrequent and usually controlled with anti-epileptic drugs. However, in some drug-resistant patients a presurgical evaluation should be considered. Hippocampal sclerosis (HS) is one of the rare causes of epilepsy in neurofibromatosis type 1, which can lead to surgery.
METHODS: We present a three-year-old child with refractory epilepsy associated with several structural brain abnormalities but normal hippocampi on brain MRI and a heterozygous variant in the NF1 gene (c.2542G > A). A complete presurgical evaluation was performed including stereo-electroencephalography (SEEG).
RESULTS: Usual seizures were recorded, and the seizure onset zone was delineated in the anterior hippocampus. Pathological examination performed after a tailored mesio-temporal resection confirmed hippocampal sclerosis, and the child achieved seizure freedom with 2 years of follow-up.
CONCLUSION: This rare pediatric case illustrates that NF1 may be associated with early-onset refractory epilepsy secondary to MRI-negative HS, supporting the major role of SEEG in the presurgical evaluation of patients with extended cortical malformations.
© 2021. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.

Entities:  

Keywords:  Children; Drug-resistant epilepsy; Invasive recording; Mesio-temporal epilepsy

Mesh:

Year:  2021        PMID: 34508273     DOI: 10.1007/s00381-021-05343-0

Source DB:  PubMed          Journal:  Childs Nerv Syst        ISSN: 0256-7040            Impact factor:   1.532


  14 in total

1.  Epilepsy in neurofibromatosis type 1.

Authors:  Anthony Pecoraro; Eric Arehart; William Gallentine; Rodney Radtke; Edward Smith; Carolyn Pizoli; Sujay Kansagra; Elie Abdelnour; Roger McLendon; Mohamad A Mikati
Journal:  Epilepsy Behav       Date:  2017-07-18       Impact factor: 2.937

2.  Epilepsy in neurofibromatosis type 1: Diffuse cerebral dysfunction?

Authors:  Esra Serdaroglu; Bahadir Konuskan; Kader Karli Oguz; Gokce Gurler; Dilek Yalnizoglu; Banu Anlar
Journal:  Epilepsy Behav       Date:  2019-07-09       Impact factor: 2.937

3.  The clinicopathologic spectrum of focal cortical dysplasias: a consensus classification proposed by an ad hoc Task Force of the ILAE Diagnostic Methods Commission.

Authors:  Ingmar Blümcke; Maria Thom; Eleonora Aronica; Dawna D Armstrong; Harry V Vinters; Andre Palmini; Thomas S Jacques; Giuliano Avanzini; A James Barkovich; Giorgio Battaglia; Albert Becker; Carlos Cepeda; Fernando Cendes; Nadia Colombo; Peter Crino; J Helen Cross; Olivier Delalande; François Dubeau; John Duncan; Renzo Guerrini; Philippe Kahane; Gary Mathern; Imad Najm; Ciğdem Ozkara; Charles Raybaud; Alfonso Represa; Steven N Roper; Noriko Salamon; Andreas Schulze-Bonhage; Laura Tassi; Annamaria Vezzani; Roberto Spreafico
Journal:  Epilepsia       Date:  2010-11-10       Impact factor: 5.864

4.  Epilepsy in NF1: a systematic review of the literature.

Authors:  Pia Bernardo; Giuseppe Cinalli; Claudia Santoro
Journal:  Childs Nerv Syst       Date:  2020-07-01       Impact factor: 1.475

5.  Patterns of seizures observed in association with neurofibromatosis 1.

Authors:  B R Korf; E Carrazana; G L Holmes
Journal:  Epilepsia       Date:  1993 Jul-Aug       Impact factor: 5.864

6.  Neurofibromatosis-1 regulates neuronal and glial cell differentiation from neuroglial progenitors in vivo by both cAMP- and Ras-dependent mechanisms.

Authors:  Balazs Hegedus; Biplab Dasgupta; Jung Eun Shin; Ryan J Emnett; Elizabeth K Hart-Mahon; Lynda Elghazi; Ernesto Bernal-Mizrachi; David H Gutmann
Journal:  Cell Stem Cell       Date:  2007-10-11       Impact factor: 24.633

7.  Epilepsy in neurofibromatosis 1.

Authors:  Rossella Vivarelli; Salvatore Grosso; Fulvia Calabrese; MariaAngela Farnetani; Rosanna Di Bartolo; Guido Morgese; Paolo Balestri
Journal:  J Child Neurol       Date:  2003-05       Impact factor: 1.987

Review 8.  Neurofibromatosis type 1 (NF1): diagnosis and management.

Authors:  Rosalie E Ferner; David H Gutmann
Journal:  Handb Clin Neurol       Date:  2013

9.  Epilepsy in individuals with neurofibromatosis type 1.

Authors:  Adam P Ostendorf; David H Gutmann; Judith L Z Weisenberg
Journal:  Epilepsia       Date:  2013-08-29       Impact factor: 5.864

10.  Malformations of cortical development in neurofibromatosis type 1.

Authors:  P Balestri; R Vivarelli; S Grosso; L Santori; M A Farnetani; P Galluzzi; G P Vatti; F Calabrese; G Morgese
Journal:  Neurology       Date:  2003-12-23       Impact factor: 9.910

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.